Phase II Study of AL-2178 (FID 109980) in the Treatment of Dry Eye

Completed · Phase 3

Conditions studied: Dry Eye

In brief

The purpose of this study is to see if Rimexolone (FID 109980) is a safe and effective treatment of dry eye.

Key facts

Study ID

NCT00471419

Run by

Alcon Research

People needed

750

Starts

2006-07-01

Expected to finish

2007-08-01

Last updated by the study team

2012-06-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• documented dry eye history
• ocular symptoms
• tear use
• dry eye ocular signs

You may not qualify if…

• Under 18

Where it is running

• Cleveland — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.